Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
German Cancer Research Center · Heidelberg University · +4 more institutions
Abstract
Immunotherapies have shown benefits across a range of human cancers, but not pancreatic ductal adenocarcinoma (PDAC). Recent evidence suggests that the immunosuppressive tumor microenvironment (TME) constitutes an important roadblock to their efficacy. The landscape of the TME differs substantially across PDAC subtypes, indicating context-specific principles of immunosuppression. In this review, we discuss how PDAC cells, the local TME, and systemic host and environmental factors drive immunosuppression in context. We argue that unraveling the mechanistic drivers of the context-specific modes of immunosuppression will open new possibilities to target PDAC more efficiently by using multimodal…
Citation impact
- FWCI
- 38.86
- Percentile
- 100%
- References
- 185
Authors
6- CFChiara FalcomatàCorresponding
German Cancer Research Center, Heidelberg University, TUM Klinikum, Technical University of Munich
- SBStefanie Bärthel
German Cancer Research Center, Heidelberg University, TUM Klinikum, Technical University of Munich
- GSGünter Schneider
German Cancer Research Center, Heidelberg University, TUM Klinikum, Universitätsmedizin Göttingen, Technical University of Munich, University of Göttingen
- RRRoland Rad
German Cancer Research Center, Technical University of Munich
- MSMarc Schmidt‐Supprian
German Cancer Research Center, Technical University of Munich
Topics & keywords
- Context (archaeology)
- Pancreatic cancer
- Tumor microenvironment
- Cancer
- Cancer research
- Computational biology
- Biology
- Medicine
Funding
- WSWilhelm Sander-StiftungAwards: 2017.091.2, 2020.174.1, 2020.174.1 and 2017.091.2
- DFDeutsche ForschungsgemeinschaftAwards: SA 1374/4-2, DFG SA 1374/6-1, DFG SCHO 1732/2-1, SFB 1371 Project-ID 395357507 P12, SFB 1371, SFB 1371 Project-ID 395357507, Project-ID 329628492, SCHO 1732/2-1, SFB 1321, SFB 1321 Project-ID 329628492 P06, 329628492, SFB 1321 Project-ID 329628492, 395357507, DFG SA 1374/4-2, 1374/4-2
- DKDeutschen Konsortium für Translationale Krebsforschung
- HEHORIZON EUROPE European Research CouncilAward: ERC CoG No. 648521